Table 3 Resistance rates for ST171 and ST418 isolates
Antimicrobial | Resistance rate (%) | Â | Resistance rate (%) | |||||
|---|---|---|---|---|---|---|---|---|
Overall | ST171 | Other STs | P-value | Â | ST171 | ST418 | P-value | |
n = 36 | n = 10 | n = 26 |  | n = 10 | n = 9 | |||
Piperacillin/tazobactam | 94.4% | 100.0% | 92.3% | 1.000 | Â | 100.0% | 100.0% | - |
Cefazolin | 100.0% | 100.0% | 100.0% | - | Â | 100.0% | 100.0% | - |
Cefotetan | 100.0% | 100.0% | 100.0% | - | Â | 100.0% | 100.0% | - |
Ceftazidime | 100.0% | 100.0% | 100.0% | - | Â | 100.0% | 100.0% | - |
Ceftriaxone | 100.0% | 100.0% | 100.0% | - | Â | 100.0% | 100.0% | - |
Ertapenem | 100.0% | 100.0% | 100.0% | - | Â | 100.0% | 100.0% | - |
Imipenem | 100.0% | 100.0% | 100.0% | - | Â | 100.0% | 100.0% | - |
Cefepime | 88.9% | 100.0% | 84.6% | 0.559 | Â | 100.0% | 100.0% | - |
Ciprofloxacin | 88.9% | 100.0% | 84.6% | 0.559 | Â | 100.0% | 100.0% | - |
Trimethoprim/ sulfamethoxazole | 86.1% | 100.0% | 80.8% | 0.293 | Â | 100.0% | 88.9% | 0.474 |
Levofloxacin | 72.2% | 80.0% | 69.2% | 0.689 | Â | 80.0% | 100.0% | 0.474 |
Aztreonam | 52.8% | 20.0% | 65.4% | 0.025 | Â | 20.0% | 100.0% | 0.001 |
Gentamicin | 52.8% | 90.0% | 38.5% | 0.008 | Â | 90.0% | 77.8% | 0.582 |
Nitrofurantoin | 41.7% | 30.0% | 46.2% | 0.468 | Â | 30.0% | 55.6% | 0.370 |
Tobramycin | 22.2% | 60.0% | 7.7% | 0.002 | Â | 60.0% | 22.2% | 0.170 |
Amikacin | 2.8% | 10.0% | 0.0% | 0.278 | Â | 10.0% | 0.0% | 1.000 |